William J Elliott

Summary

Publications

  1. ncbi request reprint A drug dose model for predicting clinical outcomes in hypertensive coronary disease patients
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 7:654-63. 2005
  2. doi request reprint Perindopril arginine + amlodipine for the treatment of hypertension in the USA
    William J Elliott
    a Pacific Northwest University of Health Sciences, Yakima, WA, USA 1 509 249 7726 1 509 249 7799
    Expert Opin Pharmacother 16:2217-29. 2015
  3. doi request reprint Rationale for a single-pill combination of perindopril arginine and amlodipine besylate
    William J Elliott
    Division of Pharmacology, Department of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, WA Electronic address
    J Am Soc Hypertens 9:257-65. 2015
  4. doi request reprint Efficacy and safety of perindopril arginine + amlodipine in hypertension
    William J Elliott
    Division of Pharmacology, Pacific Northwest University of Health Sciences, Yakima, WA, USA Electronic address
    J Am Soc Hypertens 9:266-74. 2015
  5. doi request reprint Rationale for establishing a mechanism to increase reimbursement to hypertension specialists
    William J Elliott
    Division of Pharmacology, Pacific Northwest University of Health Sciences, Yakima, WA 98901, USA
    J Clin Hypertens (Greenwich) 15:397-403. 2013
  6. doi request reprint Do the blood pressure effects of nonsteroidal antiinflammatory drugs influence cardiovascular morbidity and mortality?
    William J Elliott
    Division of Pharmacology, Pacific Northwest University of Health Sciences, 200 University Parkway, Yakima, WA 98901, USA
    Curr Hypertens Rep 12:258-66. 2010
  7. doi request reprint What should be the blood pressure target for diabetic patients?
    William J Elliott
    Pacific Northwest University of Health Sciences, Yakima, Washington, USA
    Curr Opin Cardiol 26:308-13. 2011
  8. doi request reprint Should β blockers no longer be considered first-line therapy for the treatment of essential hypertension without comorbidities?
    William J Elliott
    Preventive Medicine, Internal Medicine and Pharmacology, Division of Pharmacology, Pacific Northwest University of Health Sciences, Yakima, WA 98901, USA
    Curr Cardiol Rep 13:507-16. 2011
  9. doi request reprint Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy
    William J Elliott
    Department of Preventive Medicine, Rush Medical College at Rush University Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 11:376-82. 2009
  10. ncbi request reprint Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region
    Henry R Black
    Department of Preventive Medicine, Rush University Medical Center, Chicago, Illinois 60612, USA
    J Hypertens 23:1099-106. 2005

Detail Information

Publications38

  1. ncbi request reprint A drug dose model for predicting clinical outcomes in hypertensive coronary disease patients
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 7:654-63. 2005
    ....
  2. doi request reprint Perindopril arginine + amlodipine for the treatment of hypertension in the USA
    William J Elliott
    a Pacific Northwest University of Health Sciences, Yakima, WA, USA 1 509 249 7726 1 509 249 7799
    Expert Opin Pharmacother 16:2217-29. 2015
    ..Controlling blood pressure is a global health priority; single-pill combinations of antihypertensive agents are often prescribed to improve adherence, persistence, and outcomes...
  3. doi request reprint Rationale for a single-pill combination of perindopril arginine and amlodipine besylate
    William J Elliott
    Division of Pharmacology, Department of Biomedical Sciences, Pacific Northwest University of Health Sciences, Yakima, WA Electronic address
    J Am Soc Hypertens 9:257-65. 2015
    ..The single-pill combination of perindopril and amlodipine may be a useful addition to the antihypertensive armamentarium. ..
  4. doi request reprint Efficacy and safety of perindopril arginine + amlodipine in hypertension
    William J Elliott
    Division of Pharmacology, Pacific Northwest University of Health Sciences, Yakima, WA, USA Electronic address
    J Am Soc Hypertens 9:266-74. 2015
    ..No deaths or significant differences across groups in early discontinuation, serum potassium, or rates of total or serious adverse events or glomerular filtration, were observed...
  5. doi request reprint Rationale for establishing a mechanism to increase reimbursement to hypertension specialists
    William J Elliott
    Division of Pharmacology, Pacific Northwest University of Health Sciences, Yakima, WA 98901, USA
    J Clin Hypertens (Greenwich) 15:397-403. 2013
    ..This report sets out a rationale for increased reimbursement for care of hypertensive patients by ASH-Designated Hypertension Specialists...
  6. doi request reprint Do the blood pressure effects of nonsteroidal antiinflammatory drugs influence cardiovascular morbidity and mortality?
    William J Elliott
    Division of Pharmacology, Pacific Northwest University of Health Sciences, 200 University Parkway, Yakima, WA 98901, USA
    Curr Hypertens Rep 12:258-66. 2010
    ..Many more data will become available in 2013, after the only prospective clinical trial involving cardiovascular end points is completed...
  7. doi request reprint What should be the blood pressure target for diabetic patients?
    William J Elliott
    Pacific Northwest University of Health Sciences, Yakima, Washington, USA
    Curr Opin Cardiol 26:308-13. 2011
    ..To summarize the pros and cons of a lower-than-usual blood pressure goal (e.g., <130/80 mmHg) for diabetic patients...
  8. doi request reprint Should β blockers no longer be considered first-line therapy for the treatment of essential hypertension without comorbidities?
    William J Elliott
    Preventive Medicine, Internal Medicine and Pharmacology, Division of Pharmacology, Pacific Northwest University of Health Sciences, Yakima, WA 98901, USA
    Curr Cardiol Rep 13:507-16. 2011
    ....
  9. doi request reprint Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy
    William J Elliott
    Department of Preventive Medicine, Rush Medical College at Rush University Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 11:376-82. 2009
    ..More widespread use of such agents, particularly those available in generic formulations or in low-cost formularies, may lead to better long-term BP control and fewer cardiovascular events...
  10. ncbi request reprint Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region
    Henry R Black
    Department of Preventive Medicine, Rush University Medical Center, Chicago, Illinois 60612, USA
    J Hypertens 23:1099-106. 2005
    ..To examine regional differences in the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial...
  11. ncbi request reprint Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial
    Henry R Black
    Rush Medical College of Rush University, Chicago, IL 60612, USA
    JAMA 289:2073-82. 2003
    ..Hypertensive patients are often given a calcium antagonist to reduce cardiovascular disease risk, but the benefit compared with other drug classes is controversial...
  12. ncbi request reprint Drug interactions and drugs that affect blood pressure
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 8:731-7. 2006
    ....
  13. ncbi request reprint Antihypertensive, antiproteinuric therapy and myocardial infarction and stroke prevention
    Kenneth L Choi
    Department of Preventive Medicine, Rush Medical College, 1700 West Van Buren Street, Suite 470, Chicago, IL 60612, USA
    Curr Hypertens Rep 7:367-73. 2005
    ..Therefore, for cardiovascular end points (as opposed to renal end points), it may be more important that the blood pressure is reduced, rather than how the process is started...
  14. pmc Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment
    Michael L Maitland
    Section of Hematology Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA
    Clin Cancer Res 15:6250-7. 2009
    ..This prospective, single-center, cohort study characterized ambulatory blood pressure monitoring as an early pharmacodynamic biomarker of VEGF signaling pathway inhibition by sorafenib...
  15. ncbi request reprint Prehypertension
    William J Elliott
    Department of Preventive Medicine, Rush Medical College, Rush University Medical Center, Chicago, IL 60612, USA
    Nat Clin Pract Cardiovasc Med 4:538-48. 2007
    ..In this Review, we attempt to summarize the recently published data concerning the epidemiology, attendant risks and potential treatment options for this important and growing public-health problem...
  16. ncbi request reprint Are chlorthalidone and hydrochlorothiazide equivalent blood-pressure-lowering medications?
    Nitin Khosla
    Department of Preventive Medicine, Rush Hypertension Clinical Research Center, Rush University Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 7:354-6. 2005
  17. doi request reprint What is the prevalence of resistant hypertension in the United States?
    Dustin R Roberie
    Pacific Northwest University of Health Sciences, Yakima, Washington 98901, USA
    Curr Opin Cardiol 27:386-91. 2012
    ..Until recently, however, the prevalence of resistant hypertension in the United States (US) was based on clinical trial registries or pharmacy databases...
  18. ncbi request reprint Resistant hypertension revisited: a comparison of two university-based cohorts
    Jay P Garg
    Department of Preventive Medicine, Rush University Medical Center, Chicago, Illinois, 60612, USA
    Am J Hypertens 18:619-26. 2005
    ..To assess whether the reasons for and treatment of RH have changed, we determined the frequency of various causes of resistance, the proportion of patients achieving goal BP, and the changes made in antihypertensive regimens...
  19. ncbi request reprint The role of calcium antagonists in stroke prevention
    William J Elliott
    Department of Preventive Medicine, Rush Medical College, Rush University Medical Center, 1700 West Van Buren Street, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 7:5-8. 2005
    ..The risk of heart failure, however, is significantly increased (by 29%) with the initial calcium antagonist. These estimates may change as newer trials are reported...
  20. ncbi request reprint Renovascular hypertension: an update
    William J Elliott
    Department of Preventive Medicine, Rush Medical College, Rush University Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 10:522-33. 2008
    ....
  21. ncbi request reprint What factors contribute to the inadequate control of elevated blood pressure?
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612 3244, USA
    J Clin Hypertens (Greenwich) 10:20-6. 2008
    ..Single-pill, or fixed-dose, combination therapy is one approach that improves adherence, while also providing the antihypertensive efficacy needed to help patients achieve their blood pressure goals...
  22. ncbi request reprint Management of hypertension emergencies
    William J Elliott
    RUSH Medical College of RUSH University at RUSH Presbyterian St Luke s Medical Center, 1700 West Van Buren Street, Suite 470, Chicago, IL 60612, USA
    Curr Hypertens Rep 5:486-92. 2003
    ..When properly treated, "malignant hypertension" need be considered malignant no longer...
  23. ncbi request reprint Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612, USA
    Lancet 369:201-7. 2007
    ..We therefore undertook a network meta-analysis, which accounts for both direct and indirect comparisons to assess the effects of antihypertensive agents on incident diabetes...
  24. ncbi request reprint Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies
    William J Elliott
    Department of Preventive Medicine, Rush Medical College at Rush University Medical Center, Chicago, IL, USA
    J Am Board Fam Med 20:72-80. 2007
    ..To assess 1-year persistence and adherence with monotherapy using the most commonly dispensed individual agent in 4 antihypertensive drug classes: hydrochlorothiazide (HCTZ), amlodipine, lisinopril, or valsartan...
  25. doi request reprint Calcium channel blockers
    William J Elliott
    Department of Preventive Medicine, Rush Medical College, Rush University, Chicago, IL, USA
    J Clin Hypertens (Greenwich) 13:687-9. 2011
    ..Diltiazem and verapamil have important drug interaction with digoxin and cyclosporine, among others...
  26. ncbi request reprint Optimizing medication adherence in older persons with hypertension
    William J Elliott
    The Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612, USA
    Int Urol Nephrol 35:557-62. 2003
    ..Improving medication adherence would be a simple way to make antihypertensive therapies much more cost effective, since a medication that is not taken incurs all of cost, and provides no benefit to the patient...
  27. ncbi request reprint Clinical features and management of selected hypertensive emergencies
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University, Rush University Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 6:587-92. 2004
    ..Consideration should be given to secondary causes of hypertension after transfer from the intensive care unit. Because of advances in antihypertensive therapy and management, "malignant hypertension" should be malignant no longer...
  28. ncbi request reprint Differential effects of antihypertensive drugs on new-onset diabetes?
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612, USA
    Curr Hypertens Rep 7:249-56. 2005
    ..An earlier diagnosis of diabetes mellitus generally has little impact (over 5 years) on cardiovascular risk. The clinical importance of differential effects of antihypertensive drugs on incident diabetes is, therefore, much less clear...
  29. ncbi request reprint Cardiovascular events in hypertension trials of Angiotensin-converting enzyme inhibitors
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University at Rush University Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 7:2-4. 2005
    ..Although angiotensin-converting enzyme inhibitors can cause cough and angioedema (more common among blacks), angiotensin receptor blockers are currently more expensive and have fewer outcome trials to support their use...
  30. ncbi request reprint Clinical features in the management of selected hypertensive emergencies
    William J Elliott
    Department of Preventive Medicine, Rush Medical College, Rush University, Rush University Medical Center, Chicago, IL 60612, USA
    Prog Cardiovasc Dis 48:316-25. 2006
    ..Long-term follow-up to ensure adequate control of hypertension is necessary to prevent further target-organ damage and recurrence of another hypertensive emergency...
  31. ncbi request reprint Hypertension in women: the Women Take Heart project
    A lice A Furumoto-Dawson
    Department of Preventive Medicine, Rush Medical College, Rush Presbyterian St Lukes Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 5:38-46. 2003
    ..1% of self-reported hypertensives. Results from this study and national surveys indicate that hypertension detection and control remain major public health challenges in preventing cardiovascular disease in older women...
  32. ncbi request reprint Systemic hypertension
    William J Elliott
    Rush Medical College, Rush University Medical Center, Chicago, USA
    Curr Probl Cardiol 32:201-59. 2007
    ..Special circumstances exist for treatment of hypertension in pregnancy, in childhood, in the elderly, and in both extremes of blood pressure (pre-hypertension or hypertensive emergencies)...
  33. ncbi request reprint Management of hypertension in the very elderly patient
    William J Elliott
    Department of Preventive Medicine, Rush University Medical Center, 1700 W Van Buren, Suite 470, Chicago, IL 60612, USA
    Hypertension 44:800-4. 2004
    ..Its choice of a diuretic as initial therapy is consistent with other trials, but chlorthalidone is the drug with the most compelling evidence in large US trials that included very elderly patients...
  34. ncbi request reprint The economic impact of hypertension
    William J Elliott
    Department of Preventive Medicine, Rush Medical College of Rush University, Rush Presbyterian St Lukes Medical Center, Chicago, IL 60612, USA
    J Clin Hypertens (Greenwich) 5:3-13. 2003
    ..Pharmacoeconomic analyses regarding antihypertensive drug therapies, their costs, and the relevant reductions in health care expenditures are a useful framework for optimizing current strategies for hypertension management...
  35. ncbi request reprint Compliance--and improving it--in hypertension
    William J Elliott
    Rush Medical College, Chicago, USA
    Manag Care 12:56-61. 2003
    ..Compliance and persistence rates vary by drug class, but clinicians can take practical steps to improve patient adherence to any prescribed regimen. JNC-7 recognizes barriers to physician compliance with treatment recommendations...
  36. ncbi request reprint A comparison of two sphygmomanometers that may replace the traditional mercury column in the healthcare workplace
    William J Elliott
    Department of Preventive Medicine, Rush Medical College, Chicago, IL 60612, USA
    Blood Press Monit 12:23-8. 2007
    ....
  37. pmc Device-guided breathing to lower blood pressure: case report and clinical overview
    William J Elliott
    Rush Medical College, Chicago, Illinois, USA
    MedGenMed 8:23. 2006
    ..Device-guided paced breathing may offer an effective, simple, and new nonpharmacologic option for treating high BP without additional side effects, but like all lifestyle modifications, must be practiced consistently to provide benefits...
  38. ncbi request reprint Is fixed combination therapy appropriate for initial hypertension treatment?
    William J Elliott
    Department of Preventive Medicine, RUSH Medical College of RUSH University at RUSH Presbyterian St Luke s Medical Center, 1700 West Van Buren Street, Suite 470, Chicago, IL 60612, USA
    Curr Hypertens Rep 4:278-85. 2002
    ....